NCT02243696

Brief Summary

The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,694

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2014

Longer than P75 for all trials

Geographic Reach
1 country

68 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 18, 2014

Completed
9 days until next milestone

Study Start

First participant enrolled

September 27, 2014

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2019

Completed
1 year until next milestone

Results Posted

Study results publicly available

April 22, 2020

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

4.6 years

First QC Date

September 11, 2014

Results QC Date

April 8, 2020

Last Update Submit

June 8, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Percentage of Subjects With No Protego DF4 Lead Adverse Event

    Evaluate the percentage of subjects without an adverse event related to the Protego DF4 lead or header through 5 years. The endpoint is analyzed as the adverse event free-rate.

    Up to 4.5 years

  • Protego DF4 Lead Safety-Individual Adverse Event-Free Rate

    Evaluate the individual types of adverse events contributing to primary outcome measure 'Protego DF4 Lead Safety-Overall Adverse Event-Free Rate'.

    Up to 4.5 years

Secondary Outcomes (5)

  • Protego DF4 Lead Pacing Threshold Measurement

    Up to 4.5 years

  • Protego DF4 Lead Shock Impedance

    Up to 4.5 years

  • Percentage of Subjects With no Adverse Events Excluded From Primary Objectives

    Up to 4.5 years

  • Protego DF4 Lead Sensing

    Up to 4.5 years

  • Protego DF4 Lead Pacing Impedance

    Up to 4.5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients selected for participation should be from the investigators' general patient population according to the inclusion and exclusion criteria.

You may qualify if:

  • Implanted within the last 30 days or candidate for implantation of a BIOTRONIK ICD or CRT-D DF4 compatible system along with the Protego DF4 lead
  • Meets ICD or CRT-D system implant recommendations as defined in guidelines published by relevant professional societies
  • Able to understand the nature of the registry and provide informed consent
  • Available for follow-up visits on a regular basis at the investigational site for the expected 5 years of follow-up
  • Age greater than or equal to 18 years

You may not qualify if:

  • Enrolled in any investigational cardiac device trial
  • Planned cardiac surgical procedures or interventional measures within the next 6 months
  • Expected to receive heart transplantation or ventricular assist device within 1 year
  • Life expectancy of less than 1 year
  • Presence of another life-threatening, underlying illness separate from their cardiac disorder
  • Patients reporting pregnancy at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (68)

Unknown Facility

Gadsden, Alabama, United States

Location

Unknown Facility

Avondale, Arizona, United States

Location

Unknown Facility

Glendale, Arizona, United States

Location

Unknown Facility

Peoria, Arizona, United States

Location

Unknown Facility

Phoenix, Arizona, United States

Location

Unknown Facility

Escondido, California, United States

Location

Unknown Facility

Fountain Valley, California, United States

Location

Unknown Facility

Hawthorne, California, United States

Location

Unknown Facility

Los Angeles, California, United States

Location

Unknown Facility

Santa Barbara, California, United States

Location

Unknown Facility

Temecula, California, United States

Location

Unknown Facility

Torrance, California, United States

Location

Unknown Facility

Norwalk, Connecticut, United States

Location

Unknown Facility

Brooksville, Florida, United States

Location

Unknown Facility

Daytona Beach, Florida, United States

Location

Unknown Facility

Kissimmee, Florida, United States

Location

Unknown Facility

Miami, Florida, United States

Location

Unknown Facility

New Smyrna Beach, Florida, United States

Location

Unknown Facility

Orlando, Florida, United States

Location

Unknown Facility

St. Petersburg, Florida, United States

Location

Unknown Facility

Winter Park, Florida, United States

Location

Unknown Facility

Zephyrhills, Florida, United States

Location

Unknown Facility

Alton, Illinois, United States

Location

Unknown Facility

Aurora, Illinois, United States

Location

Unknown Facility

Chicago, Illinois, United States

Location

Unknown Facility

Schaumburg, Illinois, United States

Location

Unknown Facility

Fort Wayne, Indiana, United States

Location

Unknown Facility

Lexington, Kentucky, United States

Location

Unknown Facility

Owensboro, Kentucky, United States

Location

Unknown Facility

Lafayette, Louisiana, United States

Location

Unknown Facility

Lake Charles, Louisiana, United States

Location

Unknown Facility

Bangor, Maine, United States

Location

Unknown Facility

Baltimore, Maryland, United States

Location

Unknown Facility

Cumberland, Maryland, United States

Location

Unknown Facility

Worcester, Massachusetts, United States

Location

Unknown Facility

Detroit, Michigan, United States

Location

Unknown Facility

Flint, Michigan, United States

Location

Unknown Facility

Lansing, Michigan, United States

Location

Unknown Facility

Rochester Hills, Michigan, United States

Location

Unknown Facility

Wyoming, Michigan, United States

Location

Unknown Facility

Ypsilanti, Michigan, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Clifton, New Jersey, United States

Location

Unknown Facility

Mineola, New York, United States

Location

Unknown Facility

Stony Brook, New York, United States

Location

Unknown Facility

Winston-Salem, North Carolina, United States

Location

Unknown Facility

Fargo, North Dakota, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Middletown, Ohio, United States

Location

Unknown Facility

Steubenville, Ohio, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

Anderson, South Carolina, United States

Location

Unknown Facility

Columbia, South Carolina, United States

Location

Unknown Facility

Greenville, South Carolina, United States

Location

Unknown Facility

Lancaster, South Carolina, United States

Location

Unknown Facility

Mt. Pleasant, South Carolina, United States

Location

Unknown Facility

Rock Hill, South Carolina, United States

Location

Unknown Facility

Corpus Christi, Texas, United States

Location

Unknown Facility

Fort Worth, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

Kingwood, Texas, United States

Location

Unknown Facility

San Antonio, Texas, United States

Location

Unknown Facility

Tomball, Texas, United States

Location

Unknown Facility

Burlington, Vermont, United States

Location

Unknown Facility

Chesapeake, Virginia, United States

Location

Unknown Facility

Fredericksburg, Virginia, United States

Location

Unknown Facility

Norfolk, Virginia, United States

Location

Unknown Facility

Seattle, Washington, United States

Location

Results Point of Contact

Title
Clinical Studies Engineer Manager
Organization
BIOTRONIK, Inc.

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2014

First Posted

September 18, 2014

Study Start

September 27, 2014

Primary Completion

April 17, 2019

Study Completion

April 17, 2019

Last Updated

June 22, 2020

Results First Posted

April 22, 2020

Record last verified: 2020-06

Locations